Get started
Author

Shuji Terao

Observed names: S Terao, SHUJI TERAO, Terao, Shuji
OpenAlex ID: A5113725922
Consumption of oxygen: a mitochondrial-generated progression signal of advanced cancer
2012 · C C Cook, A Kim, et al. · Cell Death and Disease · 60
PDF
Zoledronate Stimulates γδ T Cells in Prostate Cancer Patients
2009 · Michio Naoe, Yoshio Ogawa, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 40
Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma
2008 · Noboru Okamura, Taro Masuda, et al. · PROTEOMICS · 38
Long-Term Outcome of Phase I/II Clinical Trial of Ad-OC-TK/VAL Gene Therapy for Hormone-Refractory Metastatic Prostate Cancer
2007 · Toshiro Shirakawa, Shuji Terao, et al. · Human Gene Therapy · 37
Potential tumor markers of renal cell carcinoma: α‐Enolase for postoperative follow up, and galectin‐1 and galectin‐3 for primary detection
2012 · Naoki Kaneko, Akinobu Gotoh, et al. · International Journal of Urology · 32
Midkine Promoter-Based Conditionally Replicative Adenovirus for Targeting Midkine-Expressing Human Bladder Cancer Model
2007 · Shuji Terao, Toshiro Shirakawa, et al. · Urology · 22
EGFR mRNA is Upregulated, but Somatic Mutations of the Gene are Hardly Found in Renal Cell Carcinoma in Japanese Patients
2005 · Toshiyuki Sakaeda, Noboru Okamura, et al. · Pharmaceutical Research · 21
The antitumour effect of {gamma}{delta} T-cells is enhanced by valproic acid-induced up-regulation of NKG2D ligands.
2010 · Toru Suzuki, Shuji Terao, et al. · PubMed · 18
Progress report on phase I/II clinical trial of Ad‐OC‐TK plus VAL therapy for metastatic or locally recurrent prostate cancer: Initial experience at Kobe University
2006 · NOBUYUKI HINATA, TOSHIRO SHIRAKAWA, et al. · International Journal of Urology · 15
Recombinant interleukin-2 enhanced the antitumor effect of ADV/RSV-HSV-tk/ACV therapy in a murine bladder cancer model.
2005 · Shuji Terao, Toshiro Shirakawa, et al. · PubMed · 15
Granulocyte‐colony stimulating factor producing urothelial carcinoma of renal pelvis
2005 · SHUJI TERAO, YUJI YAMADA, et al. · International Journal of Urology · 12
Improved gene transfer into renal carcinoma cells using adenovirus vector containing RGD motif.
2009 · Shuji Terao, Bishnu Acharya, et al. · PubMed · 11
Effects of Nafamostat Mesilate on ADP-Induced Platelet Aggregation and Disaggregation in Hemodialysis Patients
2006 · Masahiro Miyata, Toshiro Shirakawa, et al. · ASAIO Journal · 10
Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif.
2012 · Kazuhiro Hiwasa, Hisao Nagaya, et al. · PubMed · 9
A pilot study of quality of life of patients with hormone-refractory prostate cancer after gene therapy.
2009 · Shuji Terao, Toshiro Shirakawa, et al. · PubMed · 9
Fiber-substituted conditionally replicating adenovirus for oncolysis of human renal carcinoma cells.
2012 · Hisao Nagaya, Masatoshi Tagawa, et al. · PubMed · 8
Improving gene transfer in human renal carcinoma cells: Utilization of adenovirus vectors containing chimeric type 5 and type 35 fiber proteins
2010 · BISHNU ACHARYA, SHUJI TERAO, et al. · Experimental and Therapeutic Medicine · 7
PDF
Enhancement of IL-2-Induced Cytotoxicity by Interferon-α in Renal Cell Carcinoma
2011 · Michio Naoe, Yoshio Ogawa, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2
Expression of the Fluoropyrimidine-Metabolizing Enzymes in Bladder Cancers as Measured by the Danenberg Tumor Profile
2009 · Michio Naoe, Yoshio Ogawa, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2
Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter
2014 · Katsuyuki Hamada, Toshiro Shirakawa, et al. · Molecular Therapy — Methods & Clinical Development · 1
PDF
Abstract 1125: Consumption of oxygen: a mitochondrial-generated progression signal of advanced cancer
2012 · Cody C. Cook, Ara Kim, et al. · Cancer Research
Quality of Life of Patients with Hormone Refractory Prostate Cancer After Gene Therapy
2011 · Akinobu Gotoh, Shuji Terao, et al. · InTech eBooks
96 ENHANCEMENT OF γδ T CELL ANTITUMOR ACTIVITY AGAINST PROSTATE CANCER CELL THROUGH TOLL-LIKE RECEPTOR 2 AND 3 LIGAND DEPENDENT ACTIVATION
2010 · Toru Suzuki, Bishnu Acharya, et al. · The Journal of Urology
THE ANTITUMOR EFFECT OF γδT CELLS AGAINST BLADDER CANCER CELLS IS ENHANCED FOLLOWING UPREGULATION OF NKG2D LIGANDS BY VALPROIC ACID
2009 · Toru Suzuki, Bishnu Acharya, et al. · The Journal of Urology
Therapeutic Efficacy of Midkine Promoter-based Conditionally Replicative Adenovirus Vector for Targetting the Midkine-expressing Human Bladder Cancer Cells
2008 · Shuji Terao, Toshiro Shirakawa, et al. · The Journal of Urology
Works count: 32
Citation count: 369
H-index: 11
I10-index: 13
Year
Topic
Type